A bill to provide that the trademark law does not require that each drug be manufactured in a tablet which is unique as to its size, color, and shape.

referredUnited States· United States Congress· EN

Introduced

22 July 1982

Last action

—

Status

Referred to Subcommittee on Courts, Civil Liberties, and the Administration of Justice.

Summary

Amends the Lanham Trade-Mark Act to state that it is not a false designation of origin or a false description or representation whenever a drug in tablet form is the same size, color, and shape as a tablet of another drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Introduced in House
summary · EN · 22 July 1982
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/97th-congress/house-bill/6840
Open data entity: https://api.congress.gov/v3/bill/97/hr/6840